Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Alan Nierenberg, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Andrew Nierenberg and Mauricio Tohen.
Andrew Nierenberg
Connection Strength
4.989
Mauricio Tohen
  1. Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response. Psychiatry Res. 2021 Aug 29; 305:114194.
    View in: PubMed
    Score: 0.246
  2. Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome. J Psychiatr Res. 2021 08; 140:205-213.
    View in: PubMed
    Score: 0.242
  3. Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials. Depress Anxiety. 2021 02; 38(2):114-123.
    View in: PubMed
    Score: 0.227
  4. Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response. J Affect Disord. 2020 08 01; 273:131-137.
    View in: PubMed
    Score: 0.225
  5. Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. J Affect Disord. 2019 12 01; 259:164-172.
    View in: PubMed
    Score: 0.214
  6. Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors. J Affect Disord. 2019 10 01; 257:17-22.
    View in: PubMed
    Score: 0.212
  7. Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials. Acta Neuropsychiatr. 2019 Aug; 31(4):230-234.
    View in: PubMed
    Score: 0.211
  8. Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder. Bipolar Disord. 2019 06; 21(4):350-360.
    View in: PubMed
    Score: 0.203
  9. Treatment outcomes of acute bipolar depressive episode with psychosis. Depress Anxiety. 2018 05; 35(5):402-410.
    View in: PubMed
    Score: 0.191
  10. Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder. Acta Neuropsychiatr. 2018 Oct; 30(5):297-305.
    View in: PubMed
    Score: 0.190
  11. Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression. Aust N Z J Psychiatry. 2018 10; 52(10):994-1002.
    View in: PubMed
    Score: 0.189
  12. Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial. J Affect Disord. 2018 01 01; 225:563-568.
    View in: PubMed
    Score: 0.186
  13. Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189]. J Affect Disord. 2018 01 01; 225:775-777.
    View in: PubMed
    Score: 0.186
  14. Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder. J Affect Disord. 2017 12 01; 223:146-152.
    View in: PubMed
    Score: 0.185
  15. Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. J Affect Disord. 2017 08 01; 217:183-189.
    View in: PubMed
    Score: 0.181
  16. Clinical correlates of acute bipolar depressive episode with psychosis. J Affect Disord. 2017 08 01; 217:29-33.
    View in: PubMed
    Score: 0.181
  17. Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder. Depress Anxiety. 2017 03; 34(3):281-290.
    View in: PubMed
    Score: 0.179
  18. White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder. Aust N Z J Psychiatry. 2017 Apr; 51(4):355-365.
    View in: PubMed
    Score: 0.172
  19. Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study. J Affect Disord. 2016 Nov 15; 205:159-164.
    View in: PubMed
    Score: 0.172
  20. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry. 2016 Jan; 77(1):90-9.
    View in: PubMed
    Score: 0.166
  21. A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report. J Affect Disord. 2016 Mar 01; 192:212-8.
    View in: PubMed
    Score: 0.166
  22. Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. J Affect Disord. 2014 Oct; 168:439-51.
    View in: PubMed
    Score: 0.150
  23. Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clin Trials. 2014 Feb; 11(1):114-27.
    View in: PubMed
    Score: 0.144
  24. Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. J Affect Disord. 2013 Nov; 151(2):722-727.
    View in: PubMed
    Score: 0.141
  25. Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder. Psychopharmacol Bull. 2021 Mar 16; 51(2):8-19.
    View in: PubMed
    Score: 0.060
  26. Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale. J Affect Disord. 2019 03 01; 246:126-131.
    View in: PubMed
    Score: 0.051
  27. The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. J Affect Disord. 2020 04 01; 266:772-781.
    View in: PubMed
    Score: 0.050
  28. Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study. J Clin Psychiatry. 2016 Jan; 77(1):100-8.
    View in: PubMed
    Score: 0.042
  29. Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder. Acta Psychiatr Scand. 2016 Feb; 133(2):144-153.
    View in: PubMed
    Score: 0.040
  30. Psychotherapy use in bipolar disorder: Association with functioning and illness severity. Aust N Z J Psychiatry. 2015 May; 49(5):453-61.
    View in: PubMed
    Score: 0.039
  31. Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study. J Clin Psychopharmacol. 2015 Feb; 35(1):68-74.
    View in: PubMed
    Score: 0.039
  32. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disord. 2015 Mar; 17(2):212-23.
    View in: PubMed
    Score: 0.038
  33. Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. J Affect Disord. 2014 Jun; 161:30-5.
    View in: PubMed
    Score: 0.037
  34. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013 Nov; 170(11):1249-62.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.